PubMed
Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract
Sikiric et al., 2018
Healing & RecoveryResearch OnlyB
KLOW Blend
KLOW Stack · BPC-157 + TB-500 + GHK-Cu + KPV
KLOW is a popular research-community name for a four-peptide pre-blend: BPC-157, TB-500, GHK-Cu, and KPV in one vial (sometimes described as GLOW + KPV). PeptIQ includes KLOW as a searchable blend entry for protocol and inventory logging when the supplier sells a single mixed vial. Published evidence is component-level — not for a fixed FDA-approved combination — and vendor ratios vary. Prefer separate vials when you need independent dose control of each peptide.
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
- Studies cited
- 8
- Research grade
- B
- Experience
- 99
- Activity
- 67
Overall check-ins
Trackers & reports
Overview
About KLOW Blend
KLOW is a popular research-community name for a four-peptide pre-blend: BPC-157, TB-500, GHK-Cu, and KPV in one vial (sometimes described as GLOW + KPV). PeptIQ includes KLOW as a searchable blend entry for protocol and inventory logging when the supplier sells a single mixed vial. Published evidence is component-level — not for a fixed FDA-approved combination — and vendor ratios vary. Prefer separate vials when you need independent dose control of each peptide.
- Category
- Healing & Recovery
- Regulatory status
- Research Only
- Also known as
- KLOW Stack · BPC-157 + TB-500 + GHK-Cu + KPV
- Self-reports
- 43
Community
What 43 users report
43 community reports
Overall experience
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 97% · Mixed 3% · Unfavorable overall 0%
Most reported benefits
Benefits users selected when logging a favorable or mixed check-in.
Recovery
197
Most logged side effects
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Injection site irritation
5
Self-reported dose per injection
Median bucket: 2–3 mg · Most common: 2–3 mg
Reports span 0.2–5 mg
0.2–0.4 mg
46
0.4–0.6 mg
6
1–2 mg
43
2–3 mg
65
3–5 mg
37
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Commonly stacked with
How repeat users are trending
Among repeat reporters, 94% said they felt similar to their last entry, 6% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 73 days · Based on 31 repeat reporters
Research
Cited research (4)
Source
PubMed
Thymosin beta 4 and wound healing: a multifunctional peptide
Goldstein et al., 2010
Review Article
GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes
Pickart et al., 2018
PubMed
Alpha-MSH tripeptide analogs reduce inflammation
Luger et al., 2004
Tools
Explore more
Explore
More ways to learn about KLOW Blend from observational PeptIQ data.
Compare with
Related peptides
Help
Frequently asked
What do PeptIQ users report about KLOW Blend?
This page summarizes 43 anonymized self-reports from PeptIQ users who track KLOW Blend, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
How do side effects relate to overall experience for KLOW Blend?
PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.
What research is cited for KLOW Blend?
4 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
Is KLOW Blend safe to use?
This wiki does not assess safety or recommend use. KLOW Blend is listed as Research Only. Consult a licensed clinician for personal medical decisions.
What are the purported benefits and uses of KLOW Blend?
Research, primarily in animal models, suggests KLOW Blend may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.
SourceWhat is the legal status of KLOW Blend?
KLOW Blend is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified KLOW Blend as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.
SourceWhat are the known or theoretical side effects and risks of KLOW Blend?
The safety and effectiveness of KLOW Blend have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.
SourceWhat is the current state of research on KLOW Blend?
While there are over 200 published studies on KLOW Blend, the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.
Source